✦ LIBER ✦

A Double-Blind Placebo Controlled Study of Desipramine in the Treatment of ADD: I. Efficacy

✍ Scribed by BIEDERMAN, JOSEPH; BALDESSARINI, ROSS J.; WRIGHT, VIRGINIA; KNEE, DEBRA; HARMATZ, JEROLD S.

Book ID: 125438603
Publisher: Elsevier Science
Year: 1989
Tongue: English
Weight: 850 KB
Volume: 28
Category: Article
ISSN: 1527-5418
DOI: 10.1097/00004583-198909000-00022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Efficacy of Fluoxetine in the Treatm

The Efficacy of Fluoxetine in the Treatment of Premature Ejaculation: A Double-Blind Placebo Controlled Study

✍ Kara, Hayrettin; Aydin, Sabahattin; Agargun, M. Yucel; Odabas, Oner; Yilmaz, Yuk 📂 Article 📅 1996 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 198 KB

Efficacy of olanzapine monotherapy for t

Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study

✍ Wang, Man; Tong, Jian-hua; Huang, De-sheng; Zhu, Gang; Liang, Guang-ming; Du, Ho 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 272 KB

Efficacy of desmopressin (Minirin) in th

Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women

✍ Gunnar Lose; Othon Lalos; Robert M Freeman; Philip van Kerrebroeck 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Desmopressin in the Treatment of Nocturi

Desmopressin in the Treatment of Nocturia: A Double-Blind, Placebo-Controlled Study

✍ Philip van Kerrebroeck; Masoumeh Rezapour; Ariane Cortesse; Joachim Thüroff; And 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Vigabatrin in the Treatment of Epilepsy:

Vigabatrin in the Treatment of Epilepsy: A Double-Blind, Placebo-Controlled Study

✍ Tartara, A.; Manni, R.; Galimberti, C. A.; Hardenberg, J.; Orwin, J.; Perucca, E 📂 Article 📅 1986 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 611 KB

Efficacy of selegiline add on therapy to

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study

✍ Afshar Amiri; Ahmad-Ali Noorbala; Ali-Akbar Nejatisafa; Abolfazl Ghoreishi; Moha 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOI‐B), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of